Holen Sie sich die Stockscreener-App
6.52
0.61%
-0.04
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
Is Niagen Bioscience Inc. stock resilient to inflationMarket Growth Report & Entry and Exit Point Strategies - ulpravda.ru
Niagen Bioscience, Inc. (NAGE) Stock Analysis: 140.85% Upside Potential Captures Investor Attention - DirectorsTalk Interviews
Published on: 2026-01-08 21:02:30 - ulpravda.ru
Will Niagen Bioscience Inc. stock benefit from sector rotationWeekly Profit Report & Fast Momentum Stock Entry Tips - ulpravda.ru
Will Niagen Bioscience Inc. stock deliver shareholder valueJuly 2025 Momentum & Consistent Return Strategy Ideas - ulpravda.ru
Why Niagen Bioscience Inc. stock attracts global investorsJuly 2025 Gainers & Smart Swing Trading Alerts - ulpravda.ru
Published on: 2026-01-09 00:19:58 - ulpravda.ru
Should I hold or sell Niagen Bioscience Inc. stock in 20252025 Bull vs Bear & Weekly High Potential Alerts - ulpravda.ru
Niagen Bioscience: Why Discipline Matters In A Crowded Supplement Market (NASDAQ:NAGE) - Seeking Alpha
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
What date does Niagen Bioscience, Inc.'s (NAGE) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Precision Wealth Strategies LLC Makes New $1.53 Million Investment in Niagen Bioscience, Inc. $NAGE - MarketBeat
BSW Wealth Partners Takes Position in Niagen Bioscience, Inc. $NAGE - Defense World
Niagen Bioscience acquires existing nicotinamide riboside patent portfolio - MSN
Niagen Bioscience acquires patent portfolio from Queen’s University Belfast By Investing.com - Investing.com Nigeria
Niagen's ChromaDex Acquires Nicotinamide Riboside Patents From Queen's University Belfast - marketscreener.com
Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast - PharmiWeb.com
Niagen Bioscience (NAGE) Secures Key Patents, Boosts Revenue For - GuruFocus
Niagen Bioscience acquires patent portfolio from Queen’s University Belfast - Investing.com
Niagen Bioscience (NAGE) Secures Exclusive Ownership of Key Pate - GuruFocus
Niagen Bioscience Secures Full Ownership of Key NR Patents - TipRanks
Niagen Bioscience secures full ownership of key NR patents - MSN
Niagen Bioscience acquires existing core nicotinamide riboside patent portfolio from Queen's University Belfast - marketscreener.com
Niagen Bioscience Signs Patent Assignment Agreement With Queen's University Belfast - TradingView — Track All Markets
Niagen Bioscience (NAGE) secures full patent rights via new QUB deal - Stock Titan
Niagen Bioscience (STU:OCD1) EV-to-OCF : 19.90 (As of Dec. 22, 2025) - GuruFocus
Niagen Bioscience (STU:OCD1) EV-to-FCF : 20.14 (As of Dec. 22, 2025) - GuruFocus
Niagen Bioscience (FRA:OCD1) EV-to-OCF : 19.90 (As of Dec. 21, 2025) - GuruFocus
Market Outlook: Should I hold or sell Niagen Bioscience Inc. stock in 20252025 EndofYear Setup & Daily Profit Focused Screening - ulpravda.ru
Is Niagen Bioscience Inc. stock a safe buy before earningsWatch List & High Accuracy Buy Signal Tips - Улправда
Why Niagen Bioscience Inc. (OCD1) stock stays undervaluedPortfolio Profit Report & Precise Entry and Exit Recommendations - Улправда
Why Niagen Bioscience Inc. stock could see breakout soonStop Loss & AI Based Trade Execution Alerts - Улправда
Volume Recap: Why Niagen Bioscience Inc. (OCD1) stock stays undervalued2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - Улправда
Can Niagen Bioscience Inc. stock outperform in 2025 bull market2025 Stock Rankings & Smart Allocation Stock Tips - DonanımHaber
Published on: 2025-12-19 14:46:11 - DonanımHaber
Will Niagen Bioscience Inc. stock deliver better than expected guidanceJuly 2025 Short Interest & Expert Curated Trade Setups - Улправда
Is Niagen Bioscience Inc. stock vulnerable to regulatory risksQuarterly Investment Review & Free High Return Stock Watch Alerts - Улправда
How strong is Niagen Bioscience Inc. stock balance sheetWeekly Gains Summary & Long-Term Safe Investment Ideas - Улправда
Investors in Niagen Bioscience (NASDAQ:NAGE) have seen incredible returns of 320% over the past three years - Yahoo Finance
Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates - MSN
Trade Recap: Is Niagen Bioscience Inc stock a smart buy before Fed meeting2025 Market Overview & Daily Market Momentum Tracking - moha.gov.vn
Niagen Bioscience Announces $10 Million Share Buyback - MSN
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
How Niagen Bioscience Inc. (OCD1) stock reacts to fiscal policiesMarket Performance Report & Precise Buy Zone Tips - Newser
How Niagen Bioscience Inc. (OCD1) stock behaves under inflation pressureGold Moves & Low Risk High Reward Trade Ideas - Newser
A History of Outperforming Analyst Forecasts and Beating the Odds: Niagen Bioscience Inc (NAGE) - setenews.com
Can Niagen Bioscience Inc. (OCD1) stock sustain breakout momentumWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Why Niagen Bioscience Inc. (OCD1) stock benefits from AI revolutionPortfolio Performance Report & Long-Term Growth Portfolio Plans - Newser
Is Niagen Bioscience Inc a good long term investmentTop Performing Stocks & Big Profit Small Budget - earlytimes.in
Taking the lead: Niagen Bioscience Inc (NAGE) - Setenews
A Look at Niagen Bioscience (NAGE) Valuation After New Skincare Launch and Long COVID Study Results - Sahm
Niagen Bioscience (NAGE): Evaluating Valuation After Long COVID Study and Tru Niagen Beauty Launch - Yahoo Finance
Niagen Bioscience launches beauty supplement - Drug Store News
Will Niagen Bioscience Inc. (OCD1) stock justify high valuationWatch List & Stepwise Trade Signal Guides - newser.com
Is Niagen Bioscience Inc. stock a bargain at current levelsEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):